Zonisamide interactions with daclatasvir, ledipasvir/sofosbuvir and simeprevir have been changed from AMBER (Potential Interaction) to GREEN (No Interaction Expected). Increased clinical experience of zonisamide use shows that the inhibition of P-gp does not cause a clinically relevant interaction.
SPONSORS
